International Journal of Sciences: Basic and Applied Research
Abstract
COVID-19 viral disease appeared in China in December 2019 and then spread around the world, affecting millions and causing the death of thousands of people. Its danger in simple and easy infection transmission methods. Some believe that it has moved from the bat to the human and its symptoms are high temperature, dry cough and difficulty breathing, and symptoms vary from person to person, as they may not appear on some and be severe in others. Laboratory, in COVID-19 the rate of D-dimer increase so we recommended using of Enoxaparin sodium to raise the level of liquidity in the blood, thereby reducing the chance of thrombosis and reducing the value of D-dimer. In COVID-19 also we find the PO2 decrease in arterial blood gas analysis, increase liver enzyme levels, increase ferritin value and decrease the No of lymphocyte. Low percentage of lymphocytes is one of the predictions for infection with COVID-19 virus. Lymphocytes originate from the bone marrow and include B cells, T cells, and natural killer cells. COVID-19 binds to lymphocyte receptors and destroys them. In this case, we recommend using immunoglobulin to maintain these cells as an adjuvant therapy in COVID-19
